Vera Therapeutics, Inc. (VERA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Vera Therapeutics, Inc. (VERA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

VERA Income Statement

Vera Therapeutics, Inc. (VERA) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	256K	-1.13M	0	563K	0	0	0	0	-952K	-635K	0	0	-506K	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-256K	1.13M	0	-563K	0	0	0	0	952K	635K	0	0	506K	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	-	-	-	-	-100%	-100%	-	-	88.14%	-	-	-	-	-	-	-	-	-	-
Operating Expenses	112.49M	125.13M	95.33M	83.93M	79.58M	57.19M	48.91M	49.8M	37.34M	32.06M	27.66M	21.76M	21.97M	31.76M	33.58M	25.24M	15.06M	17.02M	16.59M	7.25M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	52.41M	39.12M	34.9M	27.46M	21.95M	15.92M	15.57M	9.49M	8.03M	7.39M	5.71M	5.66M	5.74M	6.15M	6.91M	5.59M	4.95M	4.47M	3.83M	3.69M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	60.08M	86.01M	59.56M	56.47M	58.08M	41.28M	33.35M	40.31M	29.31M	24.67M	21.95M	16.1M	16.23M	25.61M	26.68M	19.66M	10.11M	12.55M	12.75M	3.56M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	879K	0	-444K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-112.49M	-125.13M	-94.21M	-83.93M	-80.14M	-57.19M	-48.91M	-49.8M	-37.34M	-31.11M	-27.03M	-21.76M	-21.97M	-31.26M	-33.58M	-25.24M	-15.06M	-17.02M	-16.59M	-7.25M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-40.37%	-118.79%	-92.6%	-68.53%	-114.61%	-83.83%	-80.98%	-128.91%	-69.97%	0.47%	19.51%	13.82%	-45.91%	-83.64%	-102.48%	-248.1%	-157.43%	-260.92%	61.03%	-
EBITDA	-112.36M	-124.88M	-94.07M	-83.8M	-79.58M	-57.11M	-48.86M	-49.78M	-35.85M	-31.1M	-27.66M	-21.75M	-21.45M	-31.76M	-33.54M	-24.53M	-14.72M	-17.01M	-16.55M	-7.19M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-41.19%	-118.66%	-92.54%	-68.36%	-121.99%	-83.62%	-76.62%	-128.86%	-67.1%	2.09%	17.52%	11.34%	-45.69%	-86.72%	-102.6%	-241.05%	-153.92%	-263.43%	61.05%	-
D&A (Non-Cash Add-back)	132K	256K	135K	129K	563K	85K	55K	24K	1.5M	11K	-635K	6K	517K	-506K	44K	0	0	9K	32K	59K
EBIT	-107.63M	-119.21M	-85.47M	-78.33M	-74.66M	-49.9M	-41.55M	-44.7M	-31.8M	-26.48M	-26.53M	-19.16M	-19.25M	-29.2M	-33.58M	-24.53M	-14.72M	-16.97M	-16.83M	-7.61M
Net Interest Income	3.5M	4.53M	13.34M	3.78M	4.45M	5.11M	4.79M	2.83M	3.19M	2.28M	904K	1.22M	1.32M	749K	295K	420K	135K	-92K	-14K	5K
Interest Income	5.35M	6.36M	18.96M	5.74M	6.32M	6.91M	6.66M	4.76M	5.1M	4.19M	1.96M	2.16M	2.24M	1.62M	894K	567K	263K	26K	6K	5K
Interest Expense	1.85M	1.82M	5.63M	1.96M	1.87M	1.79M	1.87M	1.94M	1.91M	1.91M	1.06M	943K	914K	874K	599K	147K	128K	118K	20K	0
Other Income/Expense	3.02M	4.1M	3.11M	3.64M	3.61M	5.5M	5.49M	3.17M	3.63M	2.73M	1.37M	1.65M	1.81M	1.19M	1.14M	565K	204K	-64K	-261K	-359K
Pretax Income	-109.47M	-121.03M	-91.1M	-80.29M	-76.53M	-51.69M	-43.42M	-46.63M	-33.71M	-28.38M	-25.65M	-20.1M	-20.16M	-30.07M	-32.44M	-24.68M	-14.85M	-17.09M	-16.85M	-7.61M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	-1K	0	0	0	1K	0	0	0	1K	0	0	0	1K	0	0	0	1K	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	-0%	0%	0%	0%	-0%	0%	0%	0%	-0%	0%	0%	0%	-0.01%	0%
Net Income	-109.47M	-121.03M	-91.1M	-80.29M	-76.53M	-51.69M	-43.42M	-46.63M	-33.71M	-28.38M	-25.66M	-20.1M	-20.16M	-30.07M	-32.44M	-24.68M	-14.85M	-17.09M	-16.85M	-7.61M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-43.04%	-134.13%	-109.78%	-72.18%	-127.04%	-82.13%	-69.27%	-131.95%	-67.19%	5.61%	20.91%	18.54%	-35.74%	-76%	-92.55%	-224.25%	-332.15%	-262.43%	60.71%	-
Net Income (Continuing)	-109.47M	-121.03M	-91.1M	-80.29M	-76.53M	-51.69M	-43.42M	-46.63M	-33.71M	-28.38M	-25.66M	-20.1M	-20.16M	-30.07M	-32.44M	-24.68M	-14.85M	-17.09M	-16.85M	-7.61M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.52	-1.69	-1.39	-1.26	-1.20	-0.81	-0.85	-0.85	-0.62	-0.56	-0.58	-0.45	-0.46	-0.79	-1.17	-0.89	-0.55	-0.71	-0.79	-0.36
EPS Growth %	-26.67%	-108.64%	-63.53%	-48.24%	-93.55%	-44.64%	-46.55%	-88.89%	-34.78%	29.11%	50.43%	49.44%	16.36%	-11.27%	-48.1%	-147.22%	-66.67%	-208.7%	62.2%	-
EPS (Basic)	-1.52	-1.69	-1.39	-1.26	-1.20	-0.81	-0.85	-0.85	-0.62	-0.56	-0.58	-0.45	-0.46	-0.79	-1.17	-0.89	-0.55	-0.71	-0.79	-0.36
Diluted Shares Outstanding	71.84M	71.48M	64.23M	63.85M	63.79M	63.67M	54.9M	54.9M	54.73M	50.97M	44.45M	44.36M	44.27M	37.67M	27.8M	27.22M	27.08M	24.23M	21.28M	21.27M
Basic Shares Outstanding	71.84M	71.48M	64.23M	63.85M	63.79M	63.67M	54.9M	54.9M	54.73M	50.97M	44.45M	44.36M	44.27M	37.67M	27.8M	27.22M	27.08M	24.23M	21.28M	21.27M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-